Rosiglitazone Versus a Sulfonylurea On Progression Of Atherosclerosis In Patients With Heart Disease And Type 2 Diabetes

NCT00116831 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

672

Enrollment

INDUSTRY

Sponsor class

Conditions

Atherosclerosis

Interventions

DRUG: Glipizide
DRUG: rosiglitazone maleate

Sponsor

GlaxoSmithKline